[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"psycho-oncology\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:psycho-oncology":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,54,86,118,147],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100644472","bridging-the-gap-in-psychosocial-care-for-cancer-survivors-100644472",false,"NCT07672314","Bridging the Gap in Psychosocial Care for Cancer Survivors","Bridging the Gap in Psychosocial Care for Cancer Survivors: Integrating Digital Screening With Navigation Call","BRIDGE","Inclusion Criteria:\n\n* Adults aged ≥18 years\n* Under oncological care at the USB for ≥9 months\n* Completion of primary cancer treatment (see definition below)\n* Attendance at routine oncological follow-up at USB\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Primary brain tumors\n* Severe cognitive impairment\n* Acute psychiatric symptoms that may impair the participant's ability to provide informed consent or comply with study procedures\n* Insufficient German language skills","ALL","18 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"NA","The study aims to assess the feasibility and acceptability of the implementation of a routine digital psychosocial screening combined with a psycho-oncological Navigation Call for cancer survivors after completion of primary treatment with the goal to improve identification of psychosocial needs and facilitate access to supportive care.",[27,28,29,30],"Cancer Survivorship","Psychological Distress","Psycho-Oncology","Supportive Care",[32,33,34,35,36,37,38,39,40],"Cancer survivors","Survivorship care","Digital screening","Psycho-oncology","Psychosocial distress","Patient-reported outcomes (PROs)","Navigation Call","Feasibility study","Acceptability","NOT_YET_RECRUITING","2026-06-26",{"date":44,"type":45},"2026-06-29","ACTUAL",{"date":47,"type":21},"2026-07",{"date":49,"type":21},"2028-05",{"name":51,"class":52},"University Hospital, Basel, Switzerland","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":22,"phases":64,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":5},"100634804","what-impact-does-an-initial-psycho-oncological-contact-have-on-people-with-cancer-100634804","NCT07544446","What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?","The Impact of a Standardised Initial Contact by a Psycho-oncological Counsellor on Anxiety and Depression, Quality of Life and the Use of Psycho-oncological Support in Cancer Patients: A Patient-initiated Multicentre Randomised Controlled Study - the Psycho-oncological Initial Contact Study (PICS)","PICS","Inclusion Criteria:\n\n* Patients with an oncological disease diagnosed within the last 3 months with planned or ongoing systemic oncologic treatment (e.g. chemotherapy, immunotherapy, hormone therapy) or a planned or ongoing radiotherapy\n* Patient is ≥18 years of age and legally competent\n* Patients must have understood and signed the study information and the informed consent form\n* Patients are willing and able to complete scheduled follow-up evaluations \u002F questionnaires as described in the informed consent\n* No previous contact with psycho-oncological services\n\nExclusion Criteria:\n\n* Documented severe functional impairment according to the ECOG Performance Status (ECOG 3-4)\n* Patients receiving or planned to receive treatments associated with a severe risk of toxicity (e.g., CAR-T cell therapy, myeloablative therapy)\n* Insufficient language skills in German\n* Inability to give informed consent\n* Refusal to participate in the study, unsigned informed consent",{"count":63,"type":21},148,[24],"When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and\u002For in cases of high stress, seek psycho-oncological support.\n\nThis study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.\n\nParticipants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months.\n\nThe study was developed by patients. It is being conducted simultaneously at several hospitals.",[67,29],"Cancer",[69,29,70,71,72,73,74,75],"cancer","Adults","anxiety and depression","quality of life","distress thermometer","systemic oncologic treatment","radiotherapy","2026-04-15",{"date":78,"type":45},"2026-04-22",{"date":80,"type":21},"2026-06-01",{"date":82,"type":21},"2028-12-31",{"name":84,"class":85},"Lindenhofgruppe AG","INDUSTRY",{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":92,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":94,"minAge":18,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":22,"phases":98,"briefSummary":99,"conditions":100,"keywords":104,"overallStatus":108,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":53},"100614779","psychoeducation-and-well-being-after-breast-cancer-100614779","NCT07284030","Psychoeducation and Well-Being After Breast Cancer","The Effect of a Web-Based Supportive Psychoeducation Program on Psychological Well-Being, Quality of Life and Fear of Recurrence Applied to Patients Who Completed Active Breast Cancer Treatment","Psychoeducatio","Inclusion Criteria:\n\n* Female breast cancer survivors\n* Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago\n* Currently in remission (no evidence of active disease)\n* Age between 18-65 years\n* Able to read and write Turkish\n* Access to computer or smartphone with internet connection\n* Able to participate in online video sessions via Zoom\n* Willing to provide informed consent\n\nExclusion Criteria:\n\n* Current cancer recurrence or metastatic disease\n* Active psychiatric disorder requiring treatment\n* Cognitive impairment that prevents participation in online sessions\n* Currently receiving active cancer treatment (excluding hormonal therapy)\n* Participation in another psychosocial intervention study\n* No internet access or inability to use web-based platforms\n* Male breast cancer patients\n* Unable to commit to 6-week program schedule","FEMALE","65 Years",{"count":97,"type":21},72,[24],"This randomized controlled trial evaluates the effectiveness of a web-based psychoeducation program on psychological well-being and quality of life in breast cancer survivors who completed active treatment at least one year earlier.\n\nSeventy-two women will be randomly assigned to either a 6-week online psychoeducation program plus standard care or standard care alone. The intervention consists of weekly 30-45 minute online sessions focusing on coping strategies, psychosocial adjustment, quality of life, and psychological well-being.\n\nPrimary outcomes include psychological well-being, fear of cancer recurrence, quality of life, and hopelessness, assessed at baseline, post-intervention, and 2-month follow-up.",[101,102,103,29],"Breast Cancer","Breast Cancer Survivors","Breast - Female",[105,106,107],"Breast cancer","Psychoeducation","Web-based intervention","RECRUITING","2025-12-14",{"date":111,"type":45},"2025-12-16",{"date":113,"type":45},"2025-05-01",{"date":115,"type":21},"2026-02-01",{"name":117,"class":52},"Yasemin Nazli",{"id":119,"slug":120,"hasResults":11,"nctId":121,"briefTitle":122,"officialTitle":122,"acronym":123,"eligibilityCriteria":124,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":125,"targetDuration":4,"studyType":22,"phases":127,"briefSummary":128,"conditions":129,"keywords":4,"overallStatus":108,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":146},"100490571","longitudinal-neurocognitive-psychosocial-and-health-related-quality-of-life-assessment-in-advanced-cancer-survivors-treated-with-immunotherapy-and-the-efficacy-of-integrative-neurocognitive-remediation-therapy-100490571","NCT05667857","Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy","CognIT","Inclusion Criteria:\n\n1. Non-intervention group:\n\n   * Provision of written informed consent\n   * Diagnosed with advanced cancer of any type\n   * Initiated immunotherapy (Anti-PD1, Anti-PDL1, CTLA-4, …) at least one year ago\n   * Have a confirmed normalization on whole-body 18F-FDG PET\n   * English, Dutch or French-speaking\n2. Integrative neurocognitive remediation therapy group:\n\n   * Provision of written informed consent\n   * Objective cognitive impairment and\u002For subjective cognitive complaints\n   * Confirmed normalization on whole-body 18F-FDG PET for patients (cohort 1)\n   * Disease-free (cohort 2) or no active disease for patients with CNS tumors (cohort 3)\n   * Having received a cancer therapy of any kind\n   * Having ended cancer treatment (immunotherapy, chemotherapy, radiotherapy, surgery, …) with an exception of ongoing adjuvant hormone therapy\n   * Dutch or French speaking\n\nExclusion Criteria:\n\n* severe co-morbid non cancer-related psychiatric disorders such as psychosis, obsessive compulsive disorders, eating disorders etc., patients with cognitive impairment related to dementia, and patients that are physically or mentally not able to fill in the questionnaires",{"count":126,"type":21},100,[24],"Since 2010, the field of immunotherapy has grown substantially, leading to a growing population of long-term cancer survivors treated with immunotherapy. Since cancer survivorship in immunotherapy is an emerging field, to date not much is known about psychosocial and neurocognitive survivorship-related issues in advanced cancer survivors treated with immunotherapy. Preliminary findings indicated significant psychosocial and cognitive problems in survivors of advanced melanoma persist after treatment with immunotherapy. The objective for this project is twofold. First, the investigators want to longitudinally identify survival-related problems in survivors of advanced cancer treated with immunotherapy. The second goal is to identify the efficacy of an Integrative Neuro-Cognitive Remediation Therapy (INCRT) program. The investigators will focus on the following outcomes: (1) Psychosocial consequences, such as emotional complaints, fatigue, fear of recurrence, (2) neurocognitive functioning, and (3) health-related quality of life. The INCRT combines personalized computerized cognitive training and neurocognitive strategy training, with group sessions of exercise, mindfulness, Acceptance and Commitment Therapy, and cognitive behavioral therapy.\n\nWe will have three cohorts:\n\n* Cohort 1: advanced cancer survivors treated with immunotherapy\n* Cohort 2: cancer survivors treated with cancer therapy of any kind (excluded immunotherapy), and who have subjective complaints and\u002For objective cognitive impairment\n* Cohort 3: cancer survivors of a central nervous system (CNS) tumor, who do not have active disease in the CNS, and who have subjective complaints and\u002For objective cognitive impairment\n\nIn the first part of the study, survival-related problems will be evaluated in cohort 1, in a longitudinal manner by means of a semi-structured interview at baseline, various questionnaires and a computerized neuropsychological test battery.\n\nIn the second part of the study, patients of cohort 1, 2 and 3 with subjective or objective cognitive dysfunction can follow the INCRT program. The efficacy of the INCRT is evaluated through a pre-INCRT and post-INCRT evaluation. This evaluation consist of several questionnaires and neuropsychological tests. Long-term efficacy will be evaluated by a follow-up evaluation six months after completion of the INCRT program.",[130,131,132,29,133,134,135,136,28],"Cognitive Remediation","Neuropsychology","Quality of Life","Cognitive Behavioral Therapy","Cancer Survivors","Immunotherapy","Cognitive Dysfunction","2025-01-16",{"date":139,"type":45},"2025-01-20",{"date":141,"type":45},"2022-07-13",{"date":143,"type":21},"2033-12",{"name":145,"class":52},"Universitair Ziekenhuis Brussel",2,{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":152,"acronym":4,"eligibilityCriteria":153,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":154,"enrollmentInfo":155,"targetDuration":4,"studyType":22,"phases":157,"briefSummary":158,"conditions":159,"keywords":160,"overallStatus":108,"whyStopped":4,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":167,"startDateStruct":169,"completionDateStruct":171,"leadSponsor":173,"locationsCount":53},"100537827","effects-of-music-therapy-on-psychological-states-among-cancer-patients-undergoing-mri-scans-and-a-relevant-mediator-100537827","NCT06282887","Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and a Relevant Mediator","The Effects of Music Therapy on Improving Psychological States of Cancer Patients Undergoing MRI Scans and a Relevant Mediator","Inclusion Criteria:\n\n1. The subject is diagnosed with cancer;\n2. The subject is between 18- 60 years old;\n3. The subject understands Mandarin, Cantonese, or English;\n4. The subject did not use medication for sedatives, anxiolytics, and\u002For sleep aids;\n5. The subject is awake without cognitive disorders;\n6. the subject rates more than 0 on the 0-10 VAS for anxiety;\n7. The subject has finished primary school level education.\n\nExclusion Criteria:\n\n1. The subject withdraws the MRI scan;\n2. The subject needs other intervention(s) to complete the scan;\n3. The subject has hearing and\u002For visual impairments;\n4. The subject has a history of a severe somatic psychiatric disease or clinically diagnosed mental disorders.","60 Years",{"count":156,"type":21},80,[24],"The primary objective of this study is to examine the effects of a music therapy protocol on improving anxiety, symptom distress, and relaxation among cancer patients who are going through MRI scanning. Physiological data, such as pulse rates and respiration rates will be collected. Furthermore, data about scanning efficiency will be collected to assess if scanning efficiency is affected by the protocol implementation. The secondary study objective is to assess whether or not there is a relationship between patient attention to music during the intervention process and the changes in anxiety, symptom distress, and relaxation.",[29],[161,162,163,164,165],"MRI","Anxiety","Symptom distress","Relaxation","Music therapy","2024-12-31",{"date":168,"type":45},"2025-01-01",{"date":170,"type":45},"2021-11-09",{"date":172,"type":21},"2026-01-10",{"name":174,"class":52},"Guangzhou Concord Cancer Center"]